KERATOCONUS & CTAK

Introducing a novel alternative to corneal transplant for patients with keratoconus. CTAK is a minimally invasive tissue addition technique that restores corneal curvature and improves vision for patients with moderate to severe keratoconus.

Keratoconus Explained

Keratoconus is a progressive eye condition that causes the cornea—the clear front part of the eye—to gradually thin and bulge into a cone shape. This can lead to significant vision impairment, often causing symptoms like halos, glare and distorted vision. In advanced cases, a corneal transplant may be necessary. However, an innovative surgical procedure called Corneal Tissue Addition Keratoplasty (CTAK) offers new hope for patients.

Understanding CTAK

CTAK represents a groundbreaking advancement in keratoconus treatment, offering a personalized, minimally invasive alternative to corneal transplants. CTAK was first introduced in 2016 and has since demonstrated remarkable success.

CTAK works by reinforcing the corneal structure through the addition of biological tissue, which helps restore vision and strengthen the cornea. Unlike synthetic inlays, this natural tissue integration significantly reduces the likelihood of long-term complications. Moreover, CTAK is highly personalized—the tissue inlay is precisely shaped using a femtosecond laser matched to an individual’s unique corneal topography. This targeted approach enhances the reshaping of an irregular cornea, leading to superior results.

Rather than merely correcting refractive errors, CTAK addresses the fundamental structural abnormalities associated with keratoconus. Perhaps most notably, it has emerged as a safe and effective alternative to corneal transplantation (penetrating keratoplasty), even for patients previously advised that a transplant was their only option.

For those previously told that a corneal transplant was their only option, CTAK serves as an innovative and effective solution.

Advantanges of CTAK

  • Enhanced Visual Clarity – CTAK Smooths and reshapes the cornea significantly improving vision and reducing distortion.

 

  • Lower Risk of Rejection – Unlike full corneal transplants, CTAK does not involve a complete tissue replacement, which minimizes the risk of immune rejection.

 

  • Enhanced Biocompatibility – Donor corneal tissue integrates seamlessly, reducing complications associated with synthetic implants.

 

  • Faster Recovery – Minimally invasive procedure allowing for quicker healing and return to daily activities.

How is CTAK Performed?

LAS Landing Page__#1

Customized Donor Tissue

Donor tissue is tailored to the patient’s unique corneal topography. The tissue is precisely cut using a femtosecond laser and gamma-irradiated to ensure sterility and durability.

LAS Landing Page__#2

Precise Channel Creation

To ensure an ultra-precise fit, the femtosecond laser is then used to create an exact-match channel within the patient’s cornea, where the donor tissue will be implanted.

LAS Landing Page__#3

Tissue Integration

Once the donor tissue is inserted, the curvature of the cornea is restored to a more natural contour for enhanced stability and improved vision.

“CTAK is a revolutionary advancement in keratoconus treatment; a promising technique
for improving visual acuity and corneal topography in individuals with keratoconus.”

Journal of Cataract and Refractive Surgery, July 2023

Amir Moarefi, MD

Expert Surgical Care

CTAK requires highly specialized expertise. Our surgeon, Dr. Amir Moarefi, has undergone extensive training at leading keratoconus centers and is dedicated to providing personalized vision correction solutions tailored to each patient’s unique needs. Dr. Moarefi is renowned for his expertise in corneal and refractive surgery. His meticulous attention to detail and patient-centered approach ensure optimal outcomes and a comfortable experience. You can trust LA Sight to deliver exceptional care and life-changing vision improvements.

Book a FREE Consultation